Effect size descriptive statistics | Null test | Heterogeneity statistics | |||||||
k | d | SE | s2 | 95% CI | Z | Q | T2 | I2 | |
Random effects model† | 24 | 0.35 | 0.05 | 0.002 | (0.26 to 0.45) | 7.13*** | 72.32† | 0.030 | 68.20 |
Study characteristics‡ | |||||||||
Study design | 0.40 | ||||||||
RCT | 21 | 0.37 | 0.05 | 0.003 | (0.26 to 0.47) | 6.80*** | 0.03 | 70.03 | |
Cluster RCT | 3 | 0.27 | 0.14 | 0.021 | (-0.01 to 0.55) | 1.87 | 0.05 | 62.55 | |
Study quality | 0.00 | ||||||||
Strong | 4 | 0.36 | 0.13 | 0.002 | (0.10 to 0.61) | 2.75** | 0.01 | 11.87 | |
Moderate | 20 | 0.35 | 0.05 | 0.003 | (0.25 to 0.46) | 6.51*** | 0.03 | 72.00 | |
Measure | 9.30** | ||||||||
Subjective | 14 | 0.26 | 0.05 | 0.002 | (0.17 to 0.35) | 5.66*** | 0.01 | 48.41 | |
Objective | 10 | 0.51 | 0.07 | 0.005 | (0.37 to 0.65) | 7.33*** | 0.01 | 29.81 | |
PA outcome | 0.33 | ||||||||
Primary | 7 | 0.32 | 0.09 | 0.009 | (0.14 to 0.50) | 3.42*** | 0.03 | 63.97 | |
Secondary | 16 | 0.39 | 0.07 | 0.004 | (0.26 to 0.51) | 5.97*** | 0.04 | 68.91 | |
Sample size | 2.83 | ||||||||
n≤150 | 13 | 0.46 | 0.08 | 0.006 | (0.30 to 0.61) | 5.76*** | 0.02 | 29.30 | |
n≥151 | 11 | 0.29 | 0.06 | 0.003 | (0.18 to 0.41) | 4.96*** | 0.03 | 77.89 | |
Participant characteristics‡ | |||||||||
Mean age | 0.20 | ||||||||
≤44 years | 9 | 0.39 | 0.10 | 0.009 | (0.20 to 0.58) | 4.09*** | 0.00 | 0.00 | |
≥45 years | 15 | 0.34 | 0.06 | 0.003 | (0.23 to 0.45) | 5.88*** | 0.04 | 77.95 | |
Population | 0.78 | ||||||||
General | 20 | 0.38 | 0.06 | 0.003 | (0.27 to 0.49) | 6.68*** | 0.04 | 71.28 | |
Clinical | 4 | 0.26 | 0.12 | 0.014 | (0.03 to 0.49) | 2.21* | 0.02 | 47.50 | |
Intervention characteristics‡ | |||||||||
Contact frequency | 14.11*** | ||||||||
<1 weekly | 14 | 0.22 | 0.05 | 0.002 | (0.14 to 0.31) | 4.98*** | 0.00 | 22.86 | |
≥1 weekly | 10 | 0.50 | 0.06 | 0.003 | (0.39 to 0.62) | 8.51*** | 0.02 | 47.60 | |
Engagement | 3.95 | ||||||||
High | 3 | 0.68 | 0.17 | 0.028 | (0.35 to 1.01) | 4.04*** | 0.18 | 74.46 | |
Moderate | 10 | 0.34 | 0.07 | 0.010 | (0.20 to 0.48) | 4.79*** | 0.03 | 63.95 | |
Low | 6 | 0.31 | 0.10 | 0.005 | (0.11 to 0.51) | 3.04** | 0.00 | 0.00 | |
Gender-tailored | 12.08*** | ||||||||
No | 12 | 0.22 | 0.05 | 0.002 | (0.12 to 0.31) | 4.53*** | 0.00 | 21.27 | |
Yes | 12 | 0.47 | 0.06 | 0.003 | (0.36 to 0.58) | 8.55*** | 0.02 | 46.82 | |
Duration | 8.72** | ||||||||
≤12 weeks | 13 | 0.46 | 0.06 | 0.003 | (0.35 to 0.57) | 8.03*** | 0.03 | 53.08 | |
≥13 weeks | 11 | 0.23 | 0.05 | 0.003 | (0.12 to 0.33) | 4.26*** | 0.00 | 25.01 | |
Theory | 8.28** | ||||||||
No | 5 | 0.15 | 0.07 | 0.005 | (0.01 to 0.30) | 2.07* | 0.00 | 0.01 | |
Yes | 19 | 0.40 | 0.05 | 0.002 | (0.31 to 0.49) | 8.84*** | 0.02 | 49.62 | |
Behaviour change techniques | 10.62*** | ||||||||
≤3 techniques | 16 | 0.24 | 0.05 | 0.002 | (0.15 to 0.34) | 5.32*** | 0.01 | 26.98 | |
≥4 techniques | 8 | 0.51 | 0.07 | 0.004 | (0.38 to 0.63) | 7.72*** | 0.03 | 59.22 |
*P≤0.05, **P≤0.01, ***P≤0.001.
†Qw value used to determine heterogeneity.
‡Qb value used to determine significant differences between moderators.
d, effect size (Cohen’s d); I2, total variance explained by moderator(s); k, number of effect sizes; s2, variance; SE, SE error; T2, between study variance in random effects model; Z, test of the null hypothesis.